Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.
GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
Nested is a London-based company founded by Matt Robinson, James Turford and Phil Cowans.
LogicBio Therapeutics is a Cambridge, Massachusetts-based biotechnology company.
Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs.
Imara is a Cambridge, Massachusetts-based biotechnology company.
Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells
Harpoon Therapeutics is a t cell recruiting antibodies.
Iterum Therapeutics is an Old Saybrook, Connecticut-based company.
Small Molecules Modulating Tumor Microenvironment